White Coat Syndrome: Causes, Long-Term Effects, and More - Healthgrades

[unable to retrieve full-text content]

White Coat Syndrome: Causes, Long-Term Effects, and More  Healthgrades

Comments

Post a Comment

Popular posts from this blog

4 Symptoms of Stress You Should Never Ignore - AARP

Image
Vadym Pastukh/Getty Images Wins and medals aren't the only things grabbing attention at this year's Olympic games in Tokyo: Mental health awareness is also in the spotlight, after U.S. star gymnast Simone Biles' decision to withdraw from some events in order to focus on her emotional well-being.  Olympians or not, we're all susceptible to stress, whether from job or family pressures or obligations like caregiving. Here are the physical and mental signs that experts say could signal trouble.   1. Insomnia and difficulty sleeping  Can't fall or stay asleep? Insomnia is a class...
Read more

Altavant nabs Boehringer, Gilead alum as new CMO - FierceBiotech

Image
Altavant nabs Boehringer, Gilead alum as new CMO - FierceBiotech Altavant nabs Boehringer, Gilead alum as new CMO - FierceBiotech Posted: 02 Mar 2020 12:00 AM PST While no longer a member of Vivek Ramaswamy's Roivant umbrella group, his former Vant company is still able to bring in the big names.   Altavant, which saw its stake recently sold off alongside a host of other 'Vants' by Ramaswamy to a subsidiary of Japanese pharma Sumitomo Dainippon Pharma, is working on a series of clinical assets for respiratory diseases. The Vant name has long drawn big names from biopharma (though they have not always stuck around for long ), but despite having a new parent, Altavant still has the pulling power to nab Howard Lazarus, M.D., as it CMO. Sponsored by Clinical Ink Successful BYOD in Any Phase This white paper discusses BYOD advantages and misconceptions, regulatory, copyright, and equivalency considerations, and a Ph...
Read more

Top pulmonology news from July: FDA updates, antibiotics in cystic fibrosis, treatment of COPD exacerbations - Healio

Image
Top pulmonology news from July: FDA updates, antibiotics in cystic fibrosis, treatment of COPD exacerbations - Healio Top pulmonology news from July: FDA updates, antibiotics in cystic fibrosis, treatment of COPD exacerbations - Healio Posted: 02 Aug 2019 06:01 AM PDT Healio Pulmonology has you covered. The Editors have compiled a list of the most-popular articles posted on Healio Pulmonology in July. See below for links to a study on reducing antibiotic use for COPD exacerbations, the outcome of an FDA advisory committee meeting on nintedanib for a rare form of interstitial lung disease, updates on treatment of respiratory infections in patients with cystic fibrosis and more. C-reactive protein testing safely reduces antibiotic use for COPD exacerbations The use of point-of-care testing for C-reactive protein to guide treatment lessened the use of antibiotics for COPD exacerbations without worsening clinical outcomes, according to a...
Read more